Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant specificity in atypical depression.

M R Liebowitz1, F M Quitkin, J W Stewart

  • 1Department of Psychiatry, College of Physicians & Surgeons, Columbia University, New York, NY.

Archives of General Psychiatry
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystic fibrosis foundation position paper: Redefining the CF care model.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

RDoC is adverse to scientific creativity.

Acta psychiatrica Scandinavica·2016
Same author

Commentary on 'Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation?'.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss.

Psychological medicine·2010
Same author

Atypical depression: current status and relevance to melancholia.

Acta psychiatrica Scandinavica. Supplementum·2007
Same author

Attacking chronic kidney disease: new directions for K/DOQI.

Nephrology news & issues·2002
Same journal

Reviewers Who Completed a Review During 2011.

Archives of general psychiatry·2017
Same journal

Conflicts of interest-reply.

Archives of general psychiatry·2013
Same journal

Epidemiologic evidence concerning the bereavement exclusion in major depression-reply.

Archives of general psychiatry·2013
Same journal

This month in archives of general psychiatry.

Archives of general psychiatry·2013
Same journal

About this journal.

Archives of general psychiatry·2013
Same journal

This month in archives of general psychiatry.

Archives of general psychiatry·2013
See all related articles

Phenelzine, a monoamine oxidase inhibitor, effectively treated atypical depression, outperforming imipramine and placebo. This antidepressant response was most pronounced in patients with panic attacks or hysteroid dysphoria.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Atypical depression presents unique diagnostic challenges.
  • Understanding treatment response in atypical depression is crucial for effective patient care.

Purpose of the Study:

  • To compare the efficacy of phenelzine sulfate, imipramine hydrochloride, and placebo in treating atypical depression.
  • To identify patient subgroups that may show differential treatment responses.

Main Methods:

  • A six-week, double-blind, randomized controlled trial involving 119 patients with atypical depression.
  • Patients received phenelzine sulfate, imipramine hydrochloride, or placebo.
  • Response rates were assessed, with a subset undergoing an additional six-week continuation phase.

Related Experiment Videos

Main Results:

  • Phenelzine showed a 71% response rate, imipramine 50%, and placebo 28%.
  • Phenelzine was significantly superior to both placebo and imipramine.
  • Treatment benefits were primarily observed in patients with a history of panic attacks and/or hysteroid dysphoric features.

Conclusions:

  • Phenelzine sulfate is a highly effective treatment for atypical depression, particularly in patients with specific comorbid features.
  • The findings support the classification of atypical depression as a subtype responsive to monoamine oxidase inhibitors.
  • Further research is needed to replicate these findings and elucidate the underlying mechanisms.